The FDA has granted accelerated approval to Avmapki (avutometinib) plus Fakzynja (defactinib) for the treatment of KRAS-mutated, recurrent low-grade serous ovarian cancer.

The Trump administration has terminated National Institutes of Health (NIH) grants totaling more than $1.8 billion, and the National Cancer Institute (NCI) is among the top 5 institutes with the most ...

Washington state’s attorney general alleges the Trump administration has violated a preliminary injunction intended to stop it from cutting research funding.

President Donald Trump’s proposed budget for fiscal year 2026 would reduce the NIH budget by nearly $18 billion.

Experts say the Trump administration's cancellation of more than $800 million in research focused on LGBTQ patients could harm public health.

Despite a congressional mandate to expand care for veterans, internal Veterans Affairs messages obtained by ProPublica paint a stark portrait of how chaotic cost cutting has already imperiled tests of ...

The risk of death from kidney cancer has decreased in the United States in recent years, but the risk varies by sex, race, and ethnicity, according to research published in The Oncologist.

In an interview, FDA Commissioner Marty Makary opened up about his first weeks on the job and his vision for the future.

About 156 million people in the US live in areas with unhealthy air, according to The American Lung Association’s annual "State of the Air" report.

We want you to take advantage of everything Cancer Therapy Advisor has to offer. To view unlimited content, log in or register for free.

Having a larger brain tumor at diagnosis is associated with a higher risk of death, longer hospital stays, and greater neurological deficits, a study suggests.

Patients with intermediate- or high-complexity renal tumors generally have similar outcomes with RAPN and OPN, data suggest.